Cannabis Clinical Trials

PHILADELPHIA — Children’s Hospital of Philadelphia is pairing with an Australian biopharmaceutical company in what some advocates say could be the first major effort in the United States to study the effects of medical marijuana on children with autism. Athena Zuppa, the director of the hospital’s Center for Clinical Pharmacology, will lead a team researching […]

by

BERKELEY, Calif., Dec. 15, 2017 /PRNewswire/ – Steep Hill, the global leader in cannabis science, will collaborate with University of Technology, Jamaica(UTech, JA) at this weekend’s Rastafari RootzFest, leveraging Steep Hill Express to provide accurate potency testing for the event. Steep Hill will also provide testing training to UTech, JA to help promote best practices and […]

by

SEATTLE, WA, Dec. 14, 2017 (GLOBE NEWSWIRE) — CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Ehave Inc.’s (OTCQB: EHVVF) rollout of its mental health data platform into the medical cannabis industry. The cannabis industry is projected to exceed $50 billion in the U.S. […]

by

Can Cannabis Treat Autism? In the U.S., 1 in 45 children are born with autism spectrum disorder, which can come with many debilitating symptoms including impaired communication and social skills and/or compulsive, repetitive behaviors. And severely autistic individuals can behave aggressively, potentially harming themselves. Currently, the U.S. has only approved two medications to treat the […]

by

ASX-listed MGC Pharmaceuticals is launching a unique cannabis-based psoriasis treatment for commercial sale in 2018, following successful clinical trials. MGC said on Thursday that the marijuana-derived psoriasis product, CBD Herbal Repair Cream, would be launched from January after trials earlier this year in Slovenia showed the substance was an effective treatment of skincare complaints such […]

by

SEATTLE, WA, Dec. 14, 2017 (GLOBE NEWSWIRE) — CFN Media Group (“CannabisFN”), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Ehave Inc.’s (OTCQB: EHVVF) rollout of its mental health data platform into the medical cannabis industry. The cannabis industry is projected to exceed $50 billion in the U.S. […]

by